
|Videos|June 28, 2011
Dr. Kris Discusses Tests Available for Lung Cancer
Author(s)Mark G. Kris, MD, FASCO
Dr. Kris from Memorial Sloan-Kettering Discusses Tests Available for Lung Cancer
Advertisement
Mark G. Kris, MD, the chief of Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses tests available for lung cancer patients.
FISH is a poor cousin of mutation and that virtually all mutated patients are FISH positive. Tests for mutations are more potent predictors and most trials use them. Some of the tests are done by FISH test. They look for MET amplifications and EML4-ALK as a FISH test.
Dr. Kris says the vast majority of tests are for mutations. He says
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5



































